DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 6Pharmathen SA
03 3Acino Pharma
04 3Advanz Pharma
05 21Amdipharm Mercury Company Limited
06 12Amdipharm Mercury Debtco Limited
07 3Biological E
08 1Europharmadk Aps
09 3Institut Produits Synthése (Ipsen) Ab
10 6InvaGen Pharmaceuticals Inc
11 42Ipsen
12 16Medartuum
13 35ORIFARM GROUP AS
14 1Omnia L?kemedel Ab
15 5Paranova Pharmaceuticals Ab
16 5Pharmachim Ab
17 6Sun Pharmaceutical Industries Limited
18 3Unimedic AB
19 3Zentiva
01 9Injectable Solution In Pre-Filled Syringe
02 3Injection
03 1Lanreotide 120Mg 1 Unit Parenteral Use
04 1Lanreotide 30Mg 1 Unit Parenteral Use Rp
05 1Lanreotide 60Mg 1 Unit Parenteral Use
06 1Lanreotide 90Mg 1 Unit Parenteral Use
07 3Long Acting Injectable
08 3PFS
09 1Powder And Solvent For Extended-Release Injectable Suspension
10 1Powder For Injection
11 3Pre Filled Syringe
12 6SOLUTION (EXTENDED RELEASE)
13 9SOLUTION;SUBCUTANEOUS
14 105Solution For Injection
15 3Solution For Injection For Subcutaneous
16 3Solution For Injection In Pre-Filled
17 24Blank
01 3Allowed
02 38Approved
03 9Authorized
04 1Cancelled
05 41Deregistered
06 3EU Approved
07 3Lead Market Dossiers- Under Development
08 6Marketed
09 3Originator
10 24Prescription
11 9RX
12 37Blank
01 3IPSTYL
02 4Ipstyl
03 12Ipstyl Autogel
04 6LANREOTIDE ACETATE
05 3Lanreotid "Amdipharm"
06 3Lanreotid "Pharmathen"
07 3Lanreotida Sun
08 3Lanreotide Amdipharm
09 3Lanreotide Orifarm
10 3Lanreotide Sun
11 3Lanreotide Zentiva
12 3MYRELEZ
13 3MYTOLAC
14 12Myrelez
15 12Mytolac
16 3SOMATULINE AUTOGEL
17 1SOMATULINE AUTOGEL 120
18 1SOMATULINE AUTOGEL 60
19 1SOMATULINE AUTOGEL 90
20 3SOMATULINE DEPOT
21 1Somatulina
22 16Somatulina Autogel
23 62Somatuline Autogel
24 1Somatuline Autogel 120Mg
25 1Somatuline Autogel 60Mg
26 1Somatuline Autogel 90Mg
27 1Somatuline Pr
28 9Blank
01 24Australia
02 6Canada
03 12Denmark
04 6Estonia
05 3Greece
06 6India
07 10Italy
08 6Norway
09 3South Africa
10 10Spain
11 79Sweden
12 3Switzerland
13 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60MG/0.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 60MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 90MG/0.3ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 120MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 90MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 120MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Lanreotid \"Pharmathen\"
Dosage Form : Solution For Injection
Dosage Strength : 120mg
Packaging :
Approval Date : 16-08-2021
Application Number : 28106432320
Regulatory Info : Prescription
Registration Country : Denmark
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Lanreotid \"Pharmathen\"
Dosage Form : Solution For Injection
Dosage Strength : 60mg
Packaging :
Approval Date : 16-08-2021
Application Number : 28106432120
Regulatory Info : Prescription
Registration Country : Denmark
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Lanreotid \"Pharmathen\"
Dosage Form : Solution For Injection
Dosage Strength : 90mg
Packaging :
Approval Date : 16-08-2021
Application Number : 28106432220
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 120Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 30Mg 1 Unit Parenteral Use Rp
Dosage Strength : 1 bottle IM 30 mg prolonged release + 1 Vial 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
